There is a natural decline in cognitive function as we age, particularly in processing speed and working memory. A range of modifiable factors can increase the risk of accelerated cognitive decline including hypertension, chronic inflammation, atherosclerosis, diabetes, atrial fibrillation, stroke, and impaired central nervous system glucose regulation. Given the lack of adequate interventions for cognitive decline and dementia, it is essential that treatments with the potential to reduce the risk of cognitive impairment are thoroughly explored.
Nutraceutical and lifestyle medicines, including vitamins, herbs, supplements, physical activity, and diet, have been shown to possess anti-inflammatory, antihyperglycaemic, and antihypertensive properties, suggesting their utility in targeting the pathophysiology associated with risk for cognitive decline. The purpose of this special issue was to explore the role of such complementary medicines in the modification of risk factors for cognitive decline.
Authors contributed with a range of papers including original research and review articles spanning in vitro, in vivo, and human studies that improve the understanding of the pathology involved in cognitive impairment in older age and the development of evidence-based complementary treatment strategies for cognitive decline. This collection of works provides a snapshot (that is by no means exhaustive) of current research and some of the emerging trends in this field. This special issue features 11 papers including 4 reviews and 7 original research articles. The complementary therapies explored include nutritional supplements (2 papers), herbal and traditional medicines (6 papers), physical activity (1 paper), and electroacupuncture (2 papers). A brief description of these 11 works is detailed below. 
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